Canada has defended its decision to provide corona virus vaccines from a global vaccine-sharing initiative called Kovacs.
Kovacs raises funds from rich countries to help themselves and low-income countries buy vaccines.
The plan is to deliver more than 330 million vaccines in the first half of 2021.
In this case, Canada is the only member of the G7 group of rich countries listed as a Kovacs beneficiary.
Other rich countries, including New Zealand and Singapore, have also demanded advance allocations.
Most of the first sizes available will be offered to low- and middle-income countries.
Many of those countries have not even started vaccinations. Meanwhile, Canada has vaccinated 2.29% of its population with a single dose, including 48% of health workers. Government data shows.
Except for Kovacs, Contracts for 398 million dose vaccines have been struck down by the Canadian government – The population of the country is enough to cover 37 million.
How has Canada defended this measure?
In an interview with CBC News, a Canadian broadcaster, International Development Minister Karina Gold asked why the country has now decided to access the Kovac vaccine.
“Our first priority is to ensure that vaccines are available to Canadians,” the minister said. “Kovacs’ goal is to provide vaccinations to 20% of the population of all member states, which are self-funded and donor recipients.
“Canada, like other countries, decided to make this first provision because we realize how important it is for all Canadians to have access to vaccines.”
Canada is currently facing temporary delays for two vaccines approved in the country. This has put pressure on Mr Trudeau to ensure timely vaccination.
Domestic production capacity for vaccines does not exist in Canada. Moderna offers only 78% of the planned number of sizes this week. Pfizer vaccines have also been delayed amid efforts to increase European production.
What is covax and how does it distribute vaccines?
Kovacs is working towards the development, purchase and distribution of vaccines to more than 180 countries.
It was launched in April 2020 and is led by the World Health Organization (WHO), in collaboration with the Global Vaccine Alliance and the Alliance for Infectious Disease Innovation.
Kovacs released its first vaccine distribution forecast on Wednesday, outlining how many Pfizer-Bioendech and Astrogeneca-Oxford vaccines will be delivered.
The initial volume of about 330 million doses, on average, comprises 3.3% of the total population of the 145 participating countries, the forecast said.
The forecast illustrates the challenge of vaccinating people worldwide against the corona virus at a time when access to jobs is limited and highly unequal.
Health experts say it could take years for the corona virus to be brought under control globally if vaccines are not distributed evenly.
How many early coaxial sizes will be available for Canada?
Kovacs estimates that the initial 1.9 million doses of the Astrogeneca vaccine will be shipped to Canada.
Canada contributed 40,440m (4,324m) to Canada in September, half of which were measured by about nine vaccine candidates.
20% of people in 92 low- and middle-income countries buy the dose and the other half goes to a pool of funds.
But other high-income countries with large-scale vaccines, including the UK and Israel, are not included in Kovacs’ distribution list.
On Wednesday, Kavi CEO Seth Berkeley said the group’s most important role was to “provide vaccines to countries otherwise inaccessible.”
“Will this help when countries with a lot of bilateral agreements do not take the scale?” He asked. “Of course it helps, because others get more.”